School Withdrawal in Adolescents (DESCOL)

School Withdrawal in Adolescents: Impact of the Ambulatory Child Psychiatry Therapeutic Device. Prospective Study

The aim of the study is to evaluate the impact of the outpatient ambulatory child psychiatric care system on the functioning of anxio-depressive adolescents in school retreat by describing the modalities of individual psychic functioning.

Study Overview

• Status: Terminated
• Conditions: Depression; Obsessive-Compulsive Disorder; Anxiety Disorders; Somatoform Disorders; Emotional Disorder; Behavior Disorders; Neurotic Disorders
• Intervention / Treatment: Behavioral: school withdrawal teenagers

Detailed Description

This research project concerns adolescent patients aged 12 to 17, a period of life towards psychic individualization and autonomy. It is part of an outpatient child psychiatry sector that is concerned with the multidisciplinary and institutional dimension of the care provided. These are part of a long-term patient care dynamic. It is a therapeutic accompaniment of the young person and his entourage, especially parents.

The care is integrative and multidisciplinary (psychiatrist, psychologist, educator, psychomotor, nurse). The care project is done after team discussion, several points are taken into account (clinical evaluation, demand analysis, transfer, study of different psychic movements, family dynamics). The eyes are crossed and the various references (psychodynamic, psychoanalytic, systemic). The family consultations that are always present can be associated with the individual care of the young person, and always link with the analysis of the different institutional movements. This takes place especially at the time of the weekly clinical summaries where the clinical situations of concern are evoked to allow a cross reading and multidisciplinary.

The reflection, the exchange between the various stakeholders allow to weave an institutional mesh containing. Thanks to this system, young people and their families can experience a continuous and solid relationship.

The sector is also part of a very valuable network work with the various partners involved in the daily life of the young person and their family (school institution, social services ...).

This research is intended to be as close as possible to the care we provide and is integrated into a global work whose main interest is that of the patient.

• Study Type: Observational
• Enrollment (Actual): 8

Contacts and Locations

Study Locations

• France
  • Champigny-sur-Marne, France, 94500
    • 1er secteur de psychopathologie de l'enfant et de l'adolescent du Val de Marne

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 12 years to 17 years (CHILD)
• Accepts Healthy Volunteers: N/A
• Genders Eligible for Study: All

• Sampling Method: Non-Probability Sample

Study Population

teenagers between 12 and 17 years who are anxio-depressive and school retreat

Description

Inclusion Criteria:

• New patients in the sector with a problem of school withdrawal previously educated in ordinary medium without MDPH file (Departmental House of Disabled People).
• Young people out of school: school attendance less than 50% of school time for one month (absent at least half of school time)
• Clinical diagnosis according to the International Classification of Diseases 10 (ICD 10): F32 (depressive episodes), F33 (recurrent depressive disorder), F40 (phobic anxiety disorders), F41 (other anxiety disorders), F42 (obsessive-compulsive disorders), F43 (reaction to severe stressor, and adjustment disorders), F45 (somatoform disorder), F48 (other neurotic disorders), F90 to F98 Behavioral and emotional disorders usually occurring during childhood and adolescence
• Accepting to participate in the clinical research device

Exclusion Criteria:

• Other psychiatric diagnoses (schizophrenia, BDA (acute delirious puff), TED (Invasive Disorder of Development)).
• Intellectual deficit proved
• Education in SEGPA (Section of General and Adapted Professional Education) and ULIS (Localized Unit for School Inclusion)
• Somatic illness preventing attendance at a school
• Refusal to participate in the study

Study Plan

How is the study designed?

Number of groups / cohorts

1

Cohorts and Interventions

Group / Cohort	Intervention / Treatment
School withdrawal teenagers; The study is based on questionnaries, interview with teenagers and/or their familly	Behavioral: school withdrawal teenagers; The teenagers will have 4 interview with medical team alone or with his familly in order to have questionnaries, schools reports, psychological evaluation.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
psychological assessment	interview of the teenager with a psychologist	18 months

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
school report	change in school level	18 months
familly questionnary	interview of the family with a psychologist	18 months

Collaborators and Investigators

• Sponsor: Centre Hospitalier Intercommunal Creteil
• Collaborators: University of Paris 5 - Rene Descartes

Study record dates

Study Major Dates

• Study Start (ACTUAL): March 21, 2019
• Primary Completion (ACTUAL): February 12, 2021
• Study Completion (ACTUAL): February 12, 2021

Study Registration Dates

• First Submitted: April 4, 2019
• First Submitted That Met QC Criteria: April 4, 2019
• First Posted (ACTUAL): April 5, 2019

Study Record Updates

• Last Update Posted (ACTUAL): September 20, 2021
• Last Update Submitted That Met QC Criteria: September 14, 2021
• Last Verified: June 1, 2021

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Pathologic Processes; Disease; Obsessive-Compulsive Disorder; Anxiety Disorders; Mental Disorders; Somatoform Disorders; Neurotic Disorders
• Other Study ID Numbers: DESCOL

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No